Navigation Links
Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
Date:11/10/2010

SAN DIEGO, Nov. 10, 2010 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the Lazard 7th Annual Healthcare Conference on Wednesday, November 17, 2010 at 11:30 a.m. EST (8:30 a.m. PST).  The conference is being held at the St. Regis New York.  Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical development programs.

The presentation will be webcast at the time of presentation and can be accessed on the Investor Relations page of the Company's website at www.anadyspharma.com.  Listeners are encouraged to visit the website approximately five minutes prior to each presentation to download or install any necessary software.  A replay of the presentation  will be available approximately one hour after the live webcast concludes and will be available through December 1, 2010.  

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  Anadys is preparing to initiate a Phase IIb study of ANA598, the Company's direct-acting antiviral or DAA, added to current standard of care for the treatment of hepatitis C.  The Company is also preparing to resume clinical development of ANA773, the Company's oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forw
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2009 Financial Results
2. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
3. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
4. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
5. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
6. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
7. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
8. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
9. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
11. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life ... products for advanced microarray diagnostics, today announced it will ... at 2:00 pm ET.  During the ... brief review of SQI,s recent commercialization progress and then ... veteran recently appointed to the Board of Directors of ...
(Date:8/18/2014)... August 18, 2014 According ... Market Research "Life Science Reagents Market(Products- PCR Reagent ... Chromatography, In-Vitro Diagnostic Reagents and Others; End Users- ... Clinical Laboratories, and Forensic Laboratories)- Global Industry Analysis, ... 2019", the global life science reagents market was ...
(Date:8/18/2014)... 2014 Vier führende deutsche Augenzentren ... Studie auf, in der eine Intraokularlinse (IOL) ... Sehvermögen bei allen Entfernungen verbessern, so dass ... Lese- oder Gleitsichtbrille mehr benötigen. Die neue ... Accommodating Intraocular Lens (FluidVision akkomodative Intraokularlinse) ...
(Date:8/15/2014)... LAKE FOREST, Ill. , Aug. 15, 2014 /PRNewswire/ ... the world,s leading provider of injectable drugs and infusion ... the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. ... The presentation is scheduled to begin at ...  It will be available to all interested parties through ...
Breaking Biology Technology:SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... BioLife Solutions, Inc.,(OTC Bulletin Board: BLFS), a ... storage and cryopreservation media products for cells,tissues, ... Rutgers University Cell and DNA,Repository (RUCDR), ... the Company,s CryoStor as the exclusive cryopreservation ...
... Doubles Manufacturing Capacity; Expands Global Reach with Vietnam ... Alpine Biomed Corporation, a global leader in ... doubled its manufacturing capacity and expanded its worldwide ... The company will produce and distribute medical devices ...
... Conference Call Scheduled for 5:00 p.m. ETORANGE COUNTY, Calif., ... BEC ) announced today it will host a conference ... ET to discuss the company,s first quarter 2009 results. ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )The call may be accessed by ...
Cached Biology Technology:Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media 2Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media 3Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices 2Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices 3Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes 2
(Date:8/19/2014)... Ill. A new study of 9- and 10-year-olds ... more fibrous and compact white-matter tracts in the brain ... describes the bundles of axons that carry nerve signals ... matter is associated with faster and more efficient nerve ... the open-access journal Frontiers in Human Neuroscience. , ...
(Date:8/18/2014)... 2014 ,Trustonic TEE ... smart devices  Trustonic, the leading provider ... and Fingerprint Cards AB (FPC) today announced a ... secure biometric authentication on connected devices. ... (FPC1020, FPC1021 and FPC1150) and sensor driver software ...
(Date:8/18/2014)... a new satellite image of Antarctica, and the imagery ... insight into the effects of climate change. , Thanks ... MacDonald, Dettwiler and Associates Ltd. (MDA), the prime contractor ... Network (CCIN) at UWaterloo, the mosaic is free and ... , Using Synthetic Aperture Radar with multiple polarization ...
Breaking Biology News(10 mins):Physically fit kids have beefier brain white matter than their less-fit peers 2Physically fit kids have beefier brain white matter than their less-fit peers 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4Waterloo makes public most complete Antarctic map for climate research 2
... edible dormice ( Glis glis ) are busy caring for ... to replenish their fat stores to cope with the upcoming ... pleasant taste and dormice have long been viewed as a ... fatten them up for eating, which explains the "edible" part ...
... pioneering online biology video sites, iBioSeminars and iBioMagazine, have ... with even more to offer the biology community. Following ... provide videos by world-class biologists for free. ... broad audience, says iBiology Director Sarah Goodwin PhD, including ...
... 2013 A study performed at Children,s Hospital Los Angeles ... children with optic nerve hypoplasia (ONH). Their results are reported ... Ophthalmology and Strabismus ( AAPOS ). ONH, an ... appear either as an isolated abnormality or as part of ...
Cached Biology News:Fat and fit 22 online science video pioneers combine to form new iBiology.org 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 3
... Physical Form: buffered aqueous solution. ... terminal galactose from complex carbohydrates and glycoproteins. ... galactose under conditions where the pH must ... live cells. Unit Definition: ...
... for human cardiac troponin subunit T, a 31kDa ... for contraction of cardiac muscle. It reacts with ... cells. It also cross-reacts with human skeletal troponin ... Highly purified human cardiac troponin T ...
cystatin A (N-18)...
... to offer the ATTO-TAG series of ... primary amines. Developed by Novotny and ... reagents are similar to the important ... anthracene-2,3-dicarboxaldehyde, all of which are also ...
Biology Products: